Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Biparatopic affibody engineering enables high-affinity sortilin blockade and progranulin elevation.

New biotechnology·2026
Same author

Trimerization of CD40L-specific affibody molecules using collagen domains enhances target binding and CD40 blockade.

Cellular and molecular life sciences : CMLS·2026
Same author

Combining bacterial display and protein language models to engineer a CD69-binding affibody for molecular imaging of immune activation.

Protein engineering, design & selection : PEDS·2026
Same author

Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.

Journal of biological engineering·2026
Same author

Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugs.

Protein engineering, design & selection : PEDS·2026
Same author

Increased affinity by dimerization of radiolabeled Affibody molecule ATH001 targeting PDGFRβ.

EJNMMI radiopharmacy and chemistry·2026

相关实验视频

Updated: Jul 19, 2026

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation
19:23

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation

Published on: January 16, 2019

9.2K

使用大肠杆菌显示器设计高效矩形酶基质,用于前药激活中的应用.

Anna Mestre Borras1, Hanna Mehari1, Stefan Ståhl1

  • 1Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, 106 91 Stockholm, Sweden.

Cell reports methods
|June 11, 2025
PubMed
概括

研究人员为瘤相关酶母酶设计了新的蛋白酶基质. 这一突破增强了使用蛋白酶激活前期药物的瘤向疗法,以提高治疗选择性.

关键词:
CP: 生物技术 生物技术科普:分子生物学 分子生物学大肠杆菌显示屏显示.抗体工程是针对抗体的工程.有条件激活的条件激活指导进化是指导进化的.它们是 matriptase 的基因.药物前体是药物前体.蛋白质酶基质的基质蛋白质工程工程 蛋白质工程瘤蛋白酶是一种瘤蛋白酶.

更多相关视频

Expression, Purification, Crystallization, and Enzyme Assays of Fumarylacetoacetate Hydrolase Domain-Containing Proteins
10:21

Expression, Purification, Crystallization, and Enzyme Assays of Fumarylacetoacetate Hydrolase Domain-Containing Proteins

Published on: June 20, 2019

24.0K
Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes
10:43

Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes

Published on: October 3, 2019

5.8K

相关实验视频

Last Updated: Jul 19, 2026

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation
19:23

Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation

Published on: January 16, 2019

9.2K
Expression, Purification, Crystallization, and Enzyme Assays of Fumarylacetoacetate Hydrolase Domain-Containing Proteins
10:21

Expression, Purification, Crystallization, and Enzyme Assays of Fumarylacetoacetate Hydrolase Domain-Containing Proteins

Published on: June 20, 2019

24.0K
Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes
10:43

Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes

Published on: October 3, 2019

5.8K

科学领域:

  • 生物化学 生物化学
  • 分子生物学分子生物学
  • 在瘤学瘤学.

背景情况:

  • 蛋白酶对于生物过程至关重要,包括瘤生长和组织平衡.
  • 蛋白酶激活的前期药物为瘤向治疗提供了增强的选择性.
  • 在瘤中过度表达的蛋白酶matriptase是前药激活的目标.

研究的目的:

  • 为 matriptase 设计改进的基质序列.
  • 为了提高癌症疗法的前药激活效率.

主要方法:

  • 在大肠杆菌上显示了一个具有数百万潜在基质的类库.
  • 流细胞计用于根据裂变效率对基质进行分类和隔离.
  • 顶部基质在抗体-原药系统中进行了评估.

主要成果:

  • 与以前的序列相比,设计的母质酶基板显示了40倍以上的催化效率 (kcat/KM).
  • 这些基质在抗体-原药格式中表现出异常激活.
  • 细菌显示平台在基质发现方面被证明是有效的.

结论:

  • 工程化母质酶基质具有重要的应用潜力,例如在先进抗体前期药物中的可切割链接剂.
  • 细菌显示平台是发现其他蛋白酶基质的有希望的工具.
  • 这项工作推动了针对癌症的向治疗方法的开发.